Your browser doesn't support javascript.
loading
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.
Escuriola-Ettingshausen, Carmen; Auerswald, Günter; Königs, Christoph; Kurnik, Karin; Scholz, Ute; Klamroth, Robert; Oldenburg, Johannes.
Affiliation
  • Escuriola-Ettingshausen C; Hemophilia Centre Rhein-Main - HZRM, Frankfurt-Mörfelden, Germany.
  • Auerswald G; Department of Comprehensive Care in Haemostasis and Thrombosis, Professor Hess Children's Hospital, Bremen, Germany.
  • Königs C; Department of Pediatrics and Adolescent Medicine, Centre for Hemostasis, University Hospital Frankfurt, Frankfurt, Germany.
  • Kurnik K; Department of Paediatric Haemostasis, University Children's Hospital, Munich, Germany.
  • Scholz U; Center of Haemostasis, Leipzig, Germany.
  • Klamroth R; Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum, Berlin, Germany.
  • Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Haemophilia ; 27(3): e305-e313, 2021 May.
Article in En | MEDLINE | ID: mdl-32937002
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Guideline Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Guideline Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Germany